NEW YORK, NY / ACCESSWIRE / February 8, 2018 / On Wednesday, U.S. markets failed to continue on Tuesday's gains as investors worried about rising bond yields and interest rates. The Dow Jones Industrial Average dipped 0.08 percent to close at 24,893.35, while the S&P 500 Index fell 0.50 percent to close at 2,681.66. The Nasdaq Composite Index dropped 0.90 percent to close at 7,051.98.
"The market was positioned for great earnings, great growth, and no inflation or rates moving up to any meaningful degree. Now that goldilocks environment is gone, and we're back in a normal environment where we're getting both strong growth and higher rates. That readjustment is bringing some jitters," said Alec Young, managing director of global markets research at FTSE Russell.
RDI Initiates Coverage on:
Eli Lilly and Company
Eli Lilly and Company's stock moved 1.63% lower Wednesday, to close the day at $76.72. The stock recorded a trading volume of 8,240,329 shares, which was above its three months average volume of 3,889,545 shares. In the last year, Eli Lilly and Company's shares have traded in a range of 75.71 - 89.09. The stock is currently trading 13.54% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $84.84 is greater than its 200-day moving average of $83.78. Shares of Eli Lilly and Company have fallen 11.38 roughly percent in the past month and are down 9.16 percent year-to-date.
Access RDI's Eli Lilly and Company Research Report at:
On Wednesday, shares of InspireMD recorded a trading volume of 11,437,450 shares, which was above the three months average volume of 10,059,787 shares. The stock ended the day 20.67% lower at 0.15. The share price has gained 28.92% from its 52 week low with a 52 week trading range of 0.12 - 2.83. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.17 is below its 200-day moving average of $0.32. Shares of InspireMD have gained roughly 17.36 percent in the past month and are up 20.56 percent year-to-date.
Access RDI's InspireMD, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.